Financials Nanofilm Technologies International Limited
Equities
MZH
SGXE61652363
Specialty Chemicals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 SGD | -2.70% | +5.11% | -21.31% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 2,897 | 2,520 | 913.8 | 592.1 | 481.7 | - | - |
Enterprise Value (EV) 1 | 2,712 | 2,418 | 792.3 | 465 | 400.7 | 395.6 | 388.1 |
P/E ratio | 41.8 x | 40.8 x | 20.9 x | 191 x | 21.6 x | 14.8 x | 11.9 x |
Yield | - | 0.52% | 1.58% | - | 1.17% | 2.26% | 1.46% |
Capitalization / Revenue | 13.3 x | 10.2 x | 3.85 x | 3.34 x | 2.36 x | 1.96 x | 1.74 x |
EV / Revenue | 12.4 x | 9.8 x | 3.34 x | 2.63 x | 1.96 x | 1.61 x | 1.4 x |
EV / EBITDA | 28 x | 25.3 x | 9.84 x | 11.8 x | 6.81 x | 5.17 x | 4.66 x |
EV / FCF | -131 x | -76.4 x | 36.6 x | -46.4 x | 22 x | 22.1 x | 14.8 x |
FCF Yield | -0.76% | -1.31% | 2.73% | -2.16% | 4.55% | 4.52% | 6.76% |
Price to Book | 6.72 x | 5.87 x | 2.18 x | 1.56 x | 1.22 x | 1.16 x | 1.09 x |
Nbr of stocks (in thousands) | 658,400 | 659,688 | 657,398 | 647,056 | 651,012 | - | - |
Reference price 2 | 4.400 | 3.820 | 1.390 | 0.9150 | 0.7400 | 0.7400 | 0.7400 |
Announcement Date | 26/02/21 | 23/02/22 | 21/02/23 | 26/02/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | 218.3 | 246.7 | 237.4 | 177 | 204.4 | 245.8 | 276.9 |
EBITDA 1 | - | 96.94 | 95.73 | 80.5 | 39.4 | 58.82 | 76.57 | 83.31 |
EBIT 1 | - | 77.41 | 69.89 | 49.62 | 4.946 | 24.26 | 37.89 | 45.38 |
Operating Margin | - | 35.45% | 28.33% | 20.9% | 2.79% | 11.87% | 15.41% | 16.39% |
Earnings before Tax (EBT) 1 | - | 70.28 | 69.86 | 46.12 | 3.143 | 24.93 | 37.29 | 44.95 |
Net income 1 | 35.76 | 57.62 | 62.2 | 43.81 | 3.135 | 21.9 | 32.65 | 40 |
Net margin | - | 26.39% | 25.21% | 18.45% | 1.77% | 10.71% | 13.28% | 14.44% |
EPS 2 | 0.0652 | 0.1053 | 0.0937 | 0.0664 | 0.004800 | 0.0342 | 0.0500 | 0.0620 |
Free Cash Flow 1 | - | -20.62 | -31.67 | 21.64 | -10.02 | 18.22 | 17.9 | 26.25 |
FCF margin | - | -9.45% | -12.84% | 9.12% | -5.66% | 8.91% | 7.28% | 9.48% |
FCF Conversion (EBITDA) | - | - | - | 26.89% | - | 30.97% | 23.37% | 31.51% |
FCF Conversion (Net income) | - | - | - | 49.41% | - | 83.17% | 54.81% | 65.63% |
Dividend per Share 2 | - | - | 0.0200 | 0.0220 | - | 0.008640 | 0.0168 | 0.0108 |
Announcement Date | 16/10/20 | 26/02/21 | 23/02/22 | 21/02/23 | 26/02/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 S1 | 2021 S2 | 2023 S1 |
---|---|---|---|
Net sales 1 | 96.63 | - | 73.15 |
EBITDA | - | - | - |
EBIT | - | - | - |
Operating Margin | - | - | - |
Earnings before Tax (EBT) | - | - | - |
Net income 1 | - | 44.32 | -7.649 |
Net margin | - | - | -10.46% |
EPS | 0.0268 | - | - |
Dividend per Share | - | - | - |
Announcement Date | 13/08/21 | 23/02/22 | 10/08/23 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | - | 185 | 102 | 121 | 127 | 81.1 | 86.1 | 93.7 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -20.6 | -31.7 | 21.6 | -10 | 18.2 | 17.9 | 26.3 |
ROE (net income / shareholders' equity) | - | 20.9% | 14.5% | 10.3% | 0.79% | 5.58% | 7.93% | 9.02% |
ROA (Net income/ Total Assets) | - | 14.7% | 10.4% | 6.94% | 0.51% | 3.35% | 4.81% | 5.56% |
Assets 1 | - | 391.4 | 596.9 | 631.4 | 619.7 | 653.9 | 679.5 | 719.9 |
Book Value Per Share 2 | - | 0.6500 | 0.6500 | 0.6400 | 0.5900 | 0.6100 | 0.6400 | 0.6800 |
Cash Flow per Share 2 | - | 0.1100 | 0.1100 | 0.1100 | 0.0600 | 0.0800 | 0.0900 | 0.1000 |
Capex 1 | - | 79.6 | 105 | 50.8 | 49.1 | 44.3 | 44.8 | 46.7 |
Capex / Sales | - | 36.48% | 42.51% | 21.39% | 27.72% | 21.67% | 18.24% | 16.88% |
Announcement Date | 16/10/20 | 26/02/21 | 23/02/22 | 21/02/23 | 26/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.31% | 339M | |
+16.91% | 66.18B | |
+1.64% | 49.24B | |
+16.70% | 41.72B | |
+22.58% | 26.16B | |
+12.92% | 19.75B | |
+2.79% | 17.5B | |
-23.54% | 15.63B | |
-6.24% | 15.46B | |
+2.52% | 15.43B |
- Stock Market
- Equities
- MZH Stock
- Financials Nanofilm Technologies International Limited